Repligen Corp (RGEN) Misses Q4 EPS by 3c, Raises FY12 Revenue Guidance

June 9, 2011 7:04 AM

Repligen Corp (NASDAQ: RGEN) reported Q4 EPS of ($0.06), $0.03 worse than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found